AUXILIUM PHARAMCEUTICALS INC
AUXL
AUXL was delisted on the 29th of January, 2015.
152 hedge funds and large institutions have $1.27B invested in AUXILIUM PHARAMCEUTICALS INC in 2014 Q2 according to their latest regulatory filings, with 25 funds opening new positions, 55 increasing their positions, 53 reducing their positions, and 36 closing their positions.
951% more call options, than puts
Call options by funds: $199M | Put options by funds: $19M
4% more repeat investments, than reductions
Existing positions increased: 55 | Existing positions reduced: 53
7% less funds holding
Funds holding: 163 → 152 (-11)
14% less funds holding in top 10
Funds holding in top 10: 7 → 6 (-1)
19% less capital invested
Capital invested by funds: $1.57B → $1.27B (-$299M)
31% less first-time investments, than exits
New positions opened: 25 | Existing positions closed: 36
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
+$84.9M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$28.5M |
| 3 |
AG
Artal Group
Luxembourg
|
+$14.7M |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$12.7M |
| 5 |
State Street
Boston,
Massachusetts
|
+$9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FAM
Fred Alger Management
New York
|
-$18.5M |
| 2 |
Millennium Management
New York
|
-$17.7M |
| 3 |
Wells Fargo
San Francisco,
California
|
-$11.1M |
| 4 |
Allianz Asset Management
Munich,
Germany
|
-$10.5M |
| 5 |
PI
Putnam Investments
Boston,
Massachusetts
|
-$7.56M |
AUXL Hedge Fund Activity: Q2 2014 in Review
152 of the 3,480 institutional investors tracked by Wall St. Rank reported a position in AUXILIUM PHARAMCEUTICALS INC (AUXL) for Q2 2014, worth a combined $1.27B — down 19% from $1.57B a quarter earlier.
Sellers outnumbered buyers: 36 funds closed out of AUXL and 25 opened new positions — a net loss of 11 holders — while 53 trimmed existing stakes and 55 added.
The largest buyer was Deerfield Management, adding an estimated $84.9M. The largest seller was Fred Alger Management, cutting an estimated $18.5M.
- 152 institutional investors held AUXILIUM PHARAMCEUTICALS INC (AUXL) as of Q2 2014, down from 163 in Q1 2014.
- Funds reported $1.27B of AUXILIUM PHARAMCEUTICALS INC stock for Q2 2014, down 19% quarter-over-quarter.
- 25 funds opened new AUXILIUM PHARAMCEUTICALS INC positions in Q2 2014 and 36 closed out, a net change of -11 holders.
- The largest AUXILIUM PHARAMCEUTICALS INC buyer in Q2 2014 was Deerfield Management, an estimated $84.9M added.
- The largest AUXILIUM PHARAMCEUTICALS INC seller in Q2 2014 was Fred Alger Management, an estimated $18.5M sold.
Based on aggregated 13F filings for Q2 2014.